The human pancreatic islet transcriptome: expression of candidate genes for type 1 diabetes and the impact of pro-inflammatory cytokines.
Type 1 diabetes (T1D) is an autoimmune disease in which pancreatic beta cells are killed by infiltrating immune cells and by cytokines released by these cells. Signaling events occurring in the pancreatic beta cells are decisive for their survival or death in diabetes. We have used RNA sequencing (R...
| Main Authors: | , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2012
|
| _version_ | 1826262132060061696 |
|---|---|
| author | Eizirik, D Sammeth, M Bouckenooghe, T Bottu, G Sisino, G Igoillo-Esteve, M Ortis, F Santin, I Colli, M Barthson, J Bouwens, L Hughes, L Gregory, L Lunter, G Marselli, L Marchetti, P McCarthy, M Cnop, M |
| author_facet | Eizirik, D Sammeth, M Bouckenooghe, T Bottu, G Sisino, G Igoillo-Esteve, M Ortis, F Santin, I Colli, M Barthson, J Bouwens, L Hughes, L Gregory, L Lunter, G Marselli, L Marchetti, P McCarthy, M Cnop, M |
| author_sort | Eizirik, D |
| collection | OXFORD |
| description | Type 1 diabetes (T1D) is an autoimmune disease in which pancreatic beta cells are killed by infiltrating immune cells and by cytokines released by these cells. Signaling events occurring in the pancreatic beta cells are decisive for their survival or death in diabetes. We have used RNA sequencing (RNA-seq) to identify transcripts, including splice variants, expressed in human islets of Langerhans under control conditions or following exposure to the pro-inflammatory cytokines interleukin-1β (IL-1β) and interferon-γ (IFN-γ). Based on this unique dataset, we examined whether putative candidate genes for T1D, previously identified by GWAS, are expressed in human islets. A total of 29,776 transcripts were identified as expressed in human islets. Expression of around 20% of these transcripts was modified by pro-inflammatory cytokines, including apoptosis- and inflammation-related genes. Chemokines were among the transcripts most modified by cytokines, a finding confirmed at the protein level by ELISA. Interestingly, 35% of the genes expressed in human islets undergo alternative splicing as annotated in RefSeq, and cytokines caused substantial changes in spliced transcripts. Nova1, previously considered a brain-specific regulator of mRNA splicing, is expressed in islets and its knockdown modified splicing. 25/41 of the candidate genes for T1D are expressed in islets, and cytokines modified expression of several of these transcripts. The present study doubles the number of known genes expressed in human islets and shows that cytokines modify alternative splicing in human islet cells. Importantly, it indicates that more than half of the known T1D candidate genes are expressed in human islets. This, and the production of a large number of chemokines and cytokines by cytokine-exposed islets, reinforces the concept of a dialog between pancreatic islets and the immune system in T1D. This dialog is modulated by candidate genes for the disease at both the immune system and beta cell level. |
| first_indexed | 2024-03-06T19:31:33Z |
| format | Journal article |
| id | oxford-uuid:1d9f9292-cf54-48ea-9f96-e3a3e689fa4d |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T19:31:33Z |
| publishDate | 2012 |
| record_format | dspace |
| spelling | oxford-uuid:1d9f9292-cf54-48ea-9f96-e3a3e689fa4d2022-03-26T11:12:02ZThe human pancreatic islet transcriptome: expression of candidate genes for type 1 diabetes and the impact of pro-inflammatory cytokines.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:1d9f9292-cf54-48ea-9f96-e3a3e689fa4dEnglishSymplectic Elements at Oxford2012Eizirik, DSammeth, MBouckenooghe, TBottu, GSisino, GIgoillo-Esteve, MOrtis, FSantin, IColli, MBarthson, JBouwens, LHughes, LGregory, LLunter, GMarselli, LMarchetti, PMcCarthy, MCnop, MType 1 diabetes (T1D) is an autoimmune disease in which pancreatic beta cells are killed by infiltrating immune cells and by cytokines released by these cells. Signaling events occurring in the pancreatic beta cells are decisive for their survival or death in diabetes. We have used RNA sequencing (RNA-seq) to identify transcripts, including splice variants, expressed in human islets of Langerhans under control conditions or following exposure to the pro-inflammatory cytokines interleukin-1β (IL-1β) and interferon-γ (IFN-γ). Based on this unique dataset, we examined whether putative candidate genes for T1D, previously identified by GWAS, are expressed in human islets. A total of 29,776 transcripts were identified as expressed in human islets. Expression of around 20% of these transcripts was modified by pro-inflammatory cytokines, including apoptosis- and inflammation-related genes. Chemokines were among the transcripts most modified by cytokines, a finding confirmed at the protein level by ELISA. Interestingly, 35% of the genes expressed in human islets undergo alternative splicing as annotated in RefSeq, and cytokines caused substantial changes in spliced transcripts. Nova1, previously considered a brain-specific regulator of mRNA splicing, is expressed in islets and its knockdown modified splicing. 25/41 of the candidate genes for T1D are expressed in islets, and cytokines modified expression of several of these transcripts. The present study doubles the number of known genes expressed in human islets and shows that cytokines modify alternative splicing in human islet cells. Importantly, it indicates that more than half of the known T1D candidate genes are expressed in human islets. This, and the production of a large number of chemokines and cytokines by cytokine-exposed islets, reinforces the concept of a dialog between pancreatic islets and the immune system in T1D. This dialog is modulated by candidate genes for the disease at both the immune system and beta cell level. |
| spellingShingle | Eizirik, D Sammeth, M Bouckenooghe, T Bottu, G Sisino, G Igoillo-Esteve, M Ortis, F Santin, I Colli, M Barthson, J Bouwens, L Hughes, L Gregory, L Lunter, G Marselli, L Marchetti, P McCarthy, M Cnop, M The human pancreatic islet transcriptome: expression of candidate genes for type 1 diabetes and the impact of pro-inflammatory cytokines. |
| title | The human pancreatic islet transcriptome: expression of candidate genes for type 1 diabetes and the impact of pro-inflammatory cytokines. |
| title_full | The human pancreatic islet transcriptome: expression of candidate genes for type 1 diabetes and the impact of pro-inflammatory cytokines. |
| title_fullStr | The human pancreatic islet transcriptome: expression of candidate genes for type 1 diabetes and the impact of pro-inflammatory cytokines. |
| title_full_unstemmed | The human pancreatic islet transcriptome: expression of candidate genes for type 1 diabetes and the impact of pro-inflammatory cytokines. |
| title_short | The human pancreatic islet transcriptome: expression of candidate genes for type 1 diabetes and the impact of pro-inflammatory cytokines. |
| title_sort | human pancreatic islet transcriptome expression of candidate genes for type 1 diabetes and the impact of pro inflammatory cytokines |
| work_keys_str_mv | AT eizirikd thehumanpancreaticislettranscriptomeexpressionofcandidategenesfortype1diabetesandtheimpactofproinflammatorycytokines AT sammethm thehumanpancreaticislettranscriptomeexpressionofcandidategenesfortype1diabetesandtheimpactofproinflammatorycytokines AT bouckenooghet thehumanpancreaticislettranscriptomeexpressionofcandidategenesfortype1diabetesandtheimpactofproinflammatorycytokines AT bottug thehumanpancreaticislettranscriptomeexpressionofcandidategenesfortype1diabetesandtheimpactofproinflammatorycytokines AT sisinog thehumanpancreaticislettranscriptomeexpressionofcandidategenesfortype1diabetesandtheimpactofproinflammatorycytokines AT igoilloestevem thehumanpancreaticislettranscriptomeexpressionofcandidategenesfortype1diabetesandtheimpactofproinflammatorycytokines AT ortisf thehumanpancreaticislettranscriptomeexpressionofcandidategenesfortype1diabetesandtheimpactofproinflammatorycytokines AT santini thehumanpancreaticislettranscriptomeexpressionofcandidategenesfortype1diabetesandtheimpactofproinflammatorycytokines AT collim thehumanpancreaticislettranscriptomeexpressionofcandidategenesfortype1diabetesandtheimpactofproinflammatorycytokines AT barthsonj thehumanpancreaticislettranscriptomeexpressionofcandidategenesfortype1diabetesandtheimpactofproinflammatorycytokines AT bouwensl thehumanpancreaticislettranscriptomeexpressionofcandidategenesfortype1diabetesandtheimpactofproinflammatorycytokines AT hughesl thehumanpancreaticislettranscriptomeexpressionofcandidategenesfortype1diabetesandtheimpactofproinflammatorycytokines AT gregoryl thehumanpancreaticislettranscriptomeexpressionofcandidategenesfortype1diabetesandtheimpactofproinflammatorycytokines AT lunterg thehumanpancreaticislettranscriptomeexpressionofcandidategenesfortype1diabetesandtheimpactofproinflammatorycytokines AT marsellil thehumanpancreaticislettranscriptomeexpressionofcandidategenesfortype1diabetesandtheimpactofproinflammatorycytokines AT marchettip thehumanpancreaticislettranscriptomeexpressionofcandidategenesfortype1diabetesandtheimpactofproinflammatorycytokines AT mccarthym thehumanpancreaticislettranscriptomeexpressionofcandidategenesfortype1diabetesandtheimpactofproinflammatorycytokines AT cnopm thehumanpancreaticislettranscriptomeexpressionofcandidategenesfortype1diabetesandtheimpactofproinflammatorycytokines AT eizirikd humanpancreaticislettranscriptomeexpressionofcandidategenesfortype1diabetesandtheimpactofproinflammatorycytokines AT sammethm humanpancreaticislettranscriptomeexpressionofcandidategenesfortype1diabetesandtheimpactofproinflammatorycytokines AT bouckenooghet humanpancreaticislettranscriptomeexpressionofcandidategenesfortype1diabetesandtheimpactofproinflammatorycytokines AT bottug humanpancreaticislettranscriptomeexpressionofcandidategenesfortype1diabetesandtheimpactofproinflammatorycytokines AT sisinog humanpancreaticislettranscriptomeexpressionofcandidategenesfortype1diabetesandtheimpactofproinflammatorycytokines AT igoilloestevem humanpancreaticislettranscriptomeexpressionofcandidategenesfortype1diabetesandtheimpactofproinflammatorycytokines AT ortisf humanpancreaticislettranscriptomeexpressionofcandidategenesfortype1diabetesandtheimpactofproinflammatorycytokines AT santini humanpancreaticislettranscriptomeexpressionofcandidategenesfortype1diabetesandtheimpactofproinflammatorycytokines AT collim humanpancreaticislettranscriptomeexpressionofcandidategenesfortype1diabetesandtheimpactofproinflammatorycytokines AT barthsonj humanpancreaticislettranscriptomeexpressionofcandidategenesfortype1diabetesandtheimpactofproinflammatorycytokines AT bouwensl humanpancreaticislettranscriptomeexpressionofcandidategenesfortype1diabetesandtheimpactofproinflammatorycytokines AT hughesl humanpancreaticislettranscriptomeexpressionofcandidategenesfortype1diabetesandtheimpactofproinflammatorycytokines AT gregoryl humanpancreaticislettranscriptomeexpressionofcandidategenesfortype1diabetesandtheimpactofproinflammatorycytokines AT lunterg humanpancreaticislettranscriptomeexpressionofcandidategenesfortype1diabetesandtheimpactofproinflammatorycytokines AT marsellil humanpancreaticislettranscriptomeexpressionofcandidategenesfortype1diabetesandtheimpactofproinflammatorycytokines AT marchettip humanpancreaticislettranscriptomeexpressionofcandidategenesfortype1diabetesandtheimpactofproinflammatorycytokines AT mccarthym humanpancreaticislettranscriptomeexpressionofcandidategenesfortype1diabetesandtheimpactofproinflammatorycytokines AT cnopm humanpancreaticislettranscriptomeexpressionofcandidategenesfortype1diabetesandtheimpactofproinflammatorycytokines |